Evaluation of neoadjuvant therapy by Nematode-NOSE(N-NOSE) using C. elegans
Not Applicable
- Conditions
- Esopahgeal cancer, Gastric cancer, Colorectal cancer, Pancreatic cancer, Breast Cancer
- Registration Number
- JPRN-UMIN000041401
- Lead Sponsor
- Gifu University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 167
Inclusion Criteria
Not provided
Exclusion Criteria
1.No indication for neoadjuvant therapy, 2.No agreement by the patient, 3.Active duplicated cancer (synchronous or another cancer less than 5 y. 4.Severe medical complications, 5.Severe systhemic disease and HIV. 6.Pregnant or lactating 7.Severe mental disorder 8.Urinary tract infection
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ROC-ACU for IRC (chemotaxix index reduction score)
- Secondary Outcome Measures
Name Time Method 1. ROC-AUC for CR by IRS, 2. ROC-AUC accorfing to the following deficitions) 1)IRR1(Preop-Pretreatment), 2)IRR2 (Postop-Preop), 3)IRR4(Post op-Pretreatment, 3.Image, Tumor marker, 4.Patholog, 5. DFS, OS